(Non-)Hodgkins lymphoma multiple myeloma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -diagnosed with multiple myeloma in first line or or with HL/NHL in first line or first relapse, who have undergone HDC and autologous SCT 6 to 12 weeks ago or who where recently (
Exclusion criteria
Exclusion criteria: -tandem autologous-allogeneic stem cell transplantation -Severe cognitive impairment; -Severe emotional instability; -Insufficient mastery of the Dutch language; -Presence of extensive osteolytic lesions with risk of fracture; -Serious cardiopulmonary and cardiovascular conditions; -Other disabling comorbidity interfering with the intervention program or influencing outcome parameters (a.o. having a pacemaker , epileptic seizures and poorly regulated diabetes mellitus); -Severe infections; -Relapse/progression of disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| primary outcome variables are fatigue, cardiorespiratory fitness and muscle strength. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome variables include body composition and bone mineral density, health-related quality of life, physical activity level, satisfaction with the intervention, mood disturbances, functioning in daily life and return to work. | — |
Countries
Netherlands